
Silence Therapeutics plc SLN
$ 6.14
-2.07%
Annual report 2023
added 12-13-2025
Silence Therapeutics plc EV - Enterprise Value 2011-2025 | SLN
Annual EV - Enterprise Value Silence Therapeutics plc
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 1.55 B | 682 M | 11.7 M | -17.7 M | 2.66 M | 1.61 M | 54 M | 2.01 M | 1.72 M | 959 K | 1.26 M |
All numbers in GBP currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.55 B | -17.7 M | 209 M |
EV - Enterprise Value of other stocks in the Biotechnology industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Arbutus Biopharma Corporation
ABUS
|
457 M | $ 4.79 | 2.35 % | $ 795 M | ||
|
MorphoSys AG
MOR
|
1.82 B | - | 2.43 % | $ 254 M | ||
|
Aeglea BioTherapeutics
AGLE
|
725 M | - | - | $ 1.01 B | ||
|
Aclaris Therapeutics
ACRS
|
192 M | $ 3.04 | 4.83 % | $ 235 M | ||
|
Alpine Immune Sciences
ALPN
|
363 M | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
-64.1 M | - | 4.14 % | $ 49.1 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-1.05 M | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
7.6 M | - | - | $ 10.1 M | ||
|
BioVie
BIVI
|
-12.6 M | $ 1.27 | -3.05 % | $ 1.88 M | ||
|
Aptorum Group Limited
APM
|
9.45 M | $ 1.17 | 4.46 % | $ 6.38 M | ||
|
Aptevo Therapeutics
APVO
|
3.01 M | $ 0.93 | -8.81 % | $ 257 K | ||
|
Athersys
ATHX
|
-37.4 M | - | 3.77 % | $ 22.4 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
1.95 B | - | - | $ 40.3 B | ||
|
Avenue Therapeutics
ATXI
|
-1.23 M | - | -52.27 % | $ 4.45 M | ||
|
AVROBIO
AVRO
|
-35.4 M | - | 1083.1 % | $ 745 M | ||
|
BioDelivery Sciences International
BDSI
|
445 M | - | -4.8 % | $ 255 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
3.41 B | - | -1.52 % | $ 24.7 M | ||
|
BeiGene, Ltd.
BGNE
|
253 B | - | 0.49 % | $ 251 B | ||
|
Midatech Pharma plc
MTP
|
4.79 M | - | -18.52 % | $ 27.3 M | ||
|
Bellicum Pharmaceuticals
BLCM
|
-9.74 M | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
115 M | - | -7.31 % | $ 87 M | ||
|
bluebird bio
BLUE
|
270 M | - | - | $ 546 M | ||
|
Ascendis Pharma A/S
ASND
|
726 M | $ 212.81 | 1.71 % | $ 5 B | ||
|
Calithera Biosciences
CALA
|
916 M | - | -10.95 % | $ 876 K | ||
|
Can-Fite BioPharma Ltd.
CANF
|
647 M | $ 0.18 | -25.03 % | $ 392 M | ||
|
Catalyst Biosciences
CBIO
|
38.1 M | $ 12.37 | 2.06 % | $ 814 M | ||
|
Cerevel Therapeutics Holdings
CERE
|
6.84 B | - | - | $ 7.29 B | ||
|
Alterity Therapeutics Limited
ATHE
|
-28.9 M | $ 3.1 | 0.16 % | $ 7.46 B | ||
|
Biophytis SA
BPTS
|
525 M | - | -13.47 % | $ 169 M | ||
|
Институт стволовых клеток человека
ISKJ
|
14.1 M | - | - | - | ||
|
ARCA biopharma
ABIO
|
436 M | - | 1052.0 % | $ 415 M | ||
|
Acasti Pharma
ACST
|
24 M | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
2.15 B | - | -15.15 % | $ 60.3 M | ||
|
Celsion Corporation
CLSN
|
20.7 M | - | -6.63 % | $ 13.9 M | ||
|
Albireo Pharma
ALBO
|
417 M | - | -0.23 % | $ 916 M | ||
|
BioNTech SE
BNTX
|
-6.64 B | $ 95.03 | 0.95 % | $ 27.2 B | ||
|
Corcept Therapeutics Incorporated
CORT
|
6.58 B | $ 83.59 | 1.95 % | $ 8.63 B | ||
|
Catalyst Pharmaceuticals
CPRX
|
2.05 B | $ 24.45 | 0.91 % | $ 2.9 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
2 B | $ 26.81 | 1.36 % | $ 1.3 B | ||
|
Anika Therapeutics
ANIK
|
300 M | $ 9.48 | 0.96 % | $ 139 M | ||
|
Cortexyme
CRTX
|
132 M | - | -1.05 % | $ 67.1 M | ||
|
CTI BioPharma Corp.
CTIC
|
664 M | - | - | $ 1.2 B | ||
|
Arena Pharmaceuticals
ARNA
|
5.65 B | - | -6.81 % | $ 3.04 B | ||
|
Acer Therapeutics
ACER
|
38.2 M | - | 2.71 % | $ 14 M | ||
|
Axon Enterprise
AXON
|
41.5 B | $ 591.15 | 0.02 % | $ 44.8 B | ||
|
Ayala Pharmaceuticals
AYLA
|
5.32 M | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
-15.2 M | $ 2.53 | -0.39 % | $ 15.9 M | ||
|
AstraZeneca PLC
AZN
|
57.7 B | $ 92.45 | 0.34 % | $ 96.9 B | ||
|
Celldex Therapeutics
CLDX
|
18.3 M | $ 26.83 | 0.94 % | $ 1.73 M | ||
|
Acorda Therapeutics
ACOR
|
-13.2 M | - | -24.86 % | $ 820 K |